Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pemetrexed in Patients With Advanced Neuroendocrine Tumors

This study has been completed.
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Massachusetts General Hospital
Information provided by:
Dana-Farber Cancer Institute Identifier:
First received: January 18, 2007
Last updated: August 10, 2010
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2010
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)